The current results reveal that ACACB SNP rs2268388 (reproducibly implicated in risk of nephropathy) associates with BMI in general populations and with obesity in subjects with T2D, as well as impacts gene expression in adipose and hepatic tissue. Here, ACACB is linked to kidney disorder.